Raman Singh sold $1.8M of Liquidia (LQDA)

Executed May 21, disclosed May 26, 5 days later.

Value, as filed

$1.8M

29,494 sh × $60.13

Executed

May 21

the trade date, as filed

Disclosed

May 26

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RS Raman Singh Director profile →

Raman Singh (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $1.8M of LQDA (29,494 sh × $60.13, as filed), executed May 21.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Raman Singh in LQDA

LQDASALE Liquidia Corporation $1.2M
17,492 sh across 2 lots
Exec Sep 11
Filed Sep 15 · 4:30 PM ET LQDASALE Liquidia Corporation $721K
20,000 sh × $36.04
Exec Mar 13
Filed Mar 17 · 5:30 PM ET LQDASALE Liquidia Corporation $1.2M
45,524 sh × $25.81
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $221K
7,500 sh × $29.42
Exec Sep 3 2025
Filed Sep 5 2025 · 5:30 PM ET